What's new

Human medicines European public assessment report (EPAR): Ebvallo, tabelecleucel, Date of authorisation: 16/12/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Ebvallo, tabelecleucel, Date of authorisation: 16/12/2022, Revision: 6, Status: Authorised

Feb 18, 2025 - 17:06
 0
Human medicines European public assessment report (EPAR): Ebvallo, tabelecleucel, Date of authorisation: 16/12/2022, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Ebvallo, tabelecleucel, Date of authorisation: 16/12/2022, Revision: 6, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Cimzia, certolizumab p...

Next Article

Human medicines European public assessment report (EPAR): Iclusig, ponatinib, Da...

Related Posts

Opinion/decision on a Paediatric investigation plan (PIP): VidPrevtyn Beta, SARS-CoV2 prefusion Spike delta TM (CoV-2 preS dTM) adjuvanted with AS03, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Vaccines, PIP number: P/0072/2024

Opinion/decision on a Paediatric investigation plan (PI...

Apr 14, 2025  0

Herbal medicinal product: Tribuli terrestris herba, Tribulus terrestris L., D: Draft under discussion

Herbal medicinal product: Tribuli terrestris herba, Tri...

Feb 27, 2025  0

CHMP opinions on consultation procedures

CHMP opinions on consultation procedures

Mar 5, 2025  0